Physician

Jay Wang, M.D.

According to 2025 Medicare claims, Jay Wang, M.D. (NPI: 1952509606) practices medical oncology in the Naples-Marco Island, FL market, with the plurality of this provider's patient population coming from Collier, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 34113-7328. Wang is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Wang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,510 traditional Medicare patients, billed 615,107 HCPCS/CPT codes, and received $7,023,189 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,101 prescription claims across 555 beneficiaries totaling $7,656,592 in drug costs, led by Revlimid (Lenalidomide). DME data shows 193 claims. Open Payments data shows 228 records totaling $10,970. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,697,374 to $7,656,592. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $12,882 to $946.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,353	456,776	$4,405,804
2016	1,323	550,014	$5,546,067
2017	1,318	553,846	$5,987,516
2018	1,445	643,348	$6,911,440
2019	1,592	720,872	$8,411,775
2020	1,554	760,605	$11,210,613
2021	1,538	602,827	$8,986,831
2022	1,490	658,948	$8,462,232
2023	1,381	633,388	$8,236,948
2024	1,510	615,107	$7,023,189

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	341	2,324	$2,697,374
2016	370	2,700	$3,333,248
2017	428	2,915	$4,392,030
2018	456	2,990	$5,411,028
2019	538	3,201	$6,647,412
2020	571	3,518	$7,830,925
2021	583	3,345	$7,411,708
2022	604	3,536	$8,154,530
2023	547	3,279	$6,979,368
2024	555	3,101	$7,656,592

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	53	234	$67,657
2016	29	179	$47,264
2017	25	155	$30,334
2018	52	246	$44,486
2019	48	260	$32,021
2020	53	214	$49,338
2021	53	272	$62,097
2022	39	171	$56,182
2023	N/R	127	$63,225
2024	26	193	$106,576

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	829	2,448	$97
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	323	407	$13
96372	Injection of drug or substance under skin or into muscle	420	1,586	$11
36415	Insertion of needle into vein for collection of blood sample	1,218	4,036	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	1,111	4,094	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	85	2,337	$1,701,280
Brukinsa	Zanubrutinib	45	1,350	$620,996
Orserdu	Elacestrant Hcl	24	720	$540,016
Tasigna	Nilotinib Hcl	26	728	$524,368
Xtandi	Enzalutamide	41	1,230	$477,611

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1566	Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg	N	N/R	11	$48,424
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	12	$40,207
J8560	Etoposide; oral, 50 mg	N	N/R	14	$8,270
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	19	$6,263
J8521	Capecitabine, oral, 500 mg	N	N/R	34	$1,288

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	228	$10,970	TAIHO ONCOLOGY, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jay Wang, M.D.?

Tedicare shows public-source Medicare data for Jay Wang, M.D. (NPI 1952509606), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jay Wang, M.D. have ACO affiliation data?

Jay Wang, M.D. is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to Jay Wang, M.D.?

Jay Wang, M.D. is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Jay Wang, M.D. have Open Payments data?

Jay Wang, M.D. has 228 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.